{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:46:20Z","timestamp":1794084380557,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The 2011 4th European Conference on Infections in Leukemia (ECIL4) guidelines recommend antibiotics de-escalation\/discontinuation in selected febrile neutropenia (FN) patients. We aimed to assess the impact of an antimicrobial stewardship (AMS) program based on these guidelines on antibiotics use and clinical outcomes in high-risk FN patients.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted an observational study in the hematology department of Cochin University Hospital in Paris, France. An ECIL4-based antibiotics de-escalation and discontinuation strategy was implemented jointly by the hematologists and the AMS team. The pre-intervention (January\u2013October 2018) and post-intervention (January-October 2019) periods were compared. We retrospectively collected clinical and microbiological data. We compiled antibiotics consumptions via hospital pharmacy data and standardized them by calculating defined daily doses per 1000 patient-days. We analyzed the two-monthly antibiotic consumption using an interrupted time series method and built a composite endpoint for clinical outcomes based on transfer to the intensive care unit (ICU) and\/or hospital death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 273 hospital stays (164 patients) in the pre-intervention and 217 (148 patients) in the post-intervention periods were analyzed. Patients were mainly hospitalized for intensive chemotherapy for acute leukemia or autologous stem-cell transplant for myeloma. Patients were slightly younger in the pre-intervention compared to the post-intervention period (median age 60.4 vs 65.2\u00a0years, p\u2009=\u20090.049), but otherwise comparable. After implementation of the AMS program, glycopeptide and carbapenem use decreased by 85% (p\u2009=\u20090.03) and 72% (p\u2009=\u20090.04), respectively. After adjustment on confounders, the risk of transfer to the ICU\/death decreased significantly after implementation of the AMS program (post-intervention period: odds-ratio\u2009=\u20090.29, 95% Confidence Interval: 0.15\u20130.53, p\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Implementation of a multidisciplinary AMS program for high-risk neutropenic patients was associated with lower carbapenem and glycopeptide use and improved clinical outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01084-0","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T19:02:48Z","timestamp":1648494168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Antimicrobial stewardship in high-risk febrile neutropenia patients"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-1423","authenticated-orcid":false,"given":"Adrien","family":"Contejean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryme","family":"Chentouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Alviset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Gastli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Casetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Canou\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Charlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Reboul-Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bouscary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solen","family":"Kern\u00e9is","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"issue":"12","key":"1084_CR1","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826\u201335.","journal-title":"Haematologica"},{"issue":"30","key":"1084_CR2","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018;36(30):3043\u201354.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1084_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328\u201340.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1084_CR4","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","volume":"4","author":"M Aguilar-Guisado","year":"2017","unstructured":"Aguilar-Guisado M, Espigado I, Mart\u00edn-Pe\u00f1a A, Gudiol C, Royo-Cebrecos C, Falantes J, et al. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. Lancet Haematol. 2017;4(12):e573\u201383.","journal-title":"Lancet Haematol"},{"issue":"10","key":"1084_CR5","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s10096-018-3328-1","volume":"37","author":"G la Martire","year":"2018","unstructured":"la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, et al. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis. 2018;37(10):1931\u201340.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"1084_CR6","first-page":"3221","volume":"73","author":"JA Maertens","year":"2018","unstructured":"Maertens JA, Girmenia C, Br\u00fcggemann RJ, Duarte RF, Kibbler CC, Ljungman P, et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother. 2018;73(12):3221\u201330.","journal-title":"J Antimicrob Chemother"},{"issue":"suppl_6","key":"1084_CR7","doi-asserted-by":"publisher","first-page":"vi50","DOI":"10.1093\/jac\/dky118","volume":"73","author":"M Stanic Benic","year":"2018","unstructured":"Stanic Benic M, Milanic R, Monnier AA, Gyssens IC, Adriaenssens N, Versporten A, et al. Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018;73(suppl_6):vi50-8.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1084_CR8","doi-asserted-by":"publisher","first-page":"649.e1","DOI":"10.1016\/j.cmi.2015.03.013","volume":"21","author":"E Weiss","year":"2015","unstructured":"Weiss E, Zahar J-R, Lesprit P, Ruppe E, Leone M, Chastre J, et al. Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams. Clin Microbiol Infect. 2015;21(7):649.e1-10.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1084_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"2","key":"1084_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1473-3099(16)30397-8","volume":"17","author":"T Lawes","year":"2017","unstructured":"Lawes T, Lopez-Lozano J-M, Nebot CA, Macartney G, Subbarao-Sharma R, Wares KD, et al. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lancet Infect Dis. 2017;17(2):194\u2013206.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1084_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ijantimicag.2018.08.026","volume":"52","author":"P-L Woerther","year":"2018","unstructured":"Woerther P-L, Lepeule R, Burdet C, Decousser J-W, Rupp\u00e9 \u00c9, Barbier F. Carbapenems and alternative \u03b2-lactams for the treatment of infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: what impact on intestinal colonisation resistance? Int J Antimicrob Agents. 2018;52(6):762\u201370.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1084_CR12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lef\u00e8vre","year":"2013","unstructured":"Armand-Lef\u00e8vre L, Angebault C, Barbier F, Hamelet E, Defrance G, Rupp\u00e9 E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57(3):1488\u201395.","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"1084_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"1084_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/cid\/ciz900","volume":"71","author":"BJ Webb","year":"2020","unstructured":"Webb BJ, Majers J, Healy R, Jones PB, Butler AM, Snow G, et al. Antimicrobial stewardship in a hematological malignancy unit: carbapenem reduction and decreased vancomycin-resistant enterococcus infection. Clin Infect Dis. 2020;71(4):960\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1084_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s40506-019-00189-2","volume":"11","author":"M So","year":"2019","unstructured":"So M. Antimicrobial stewardship in patients with hematological malignancies: key considerations. Curr Treat Options Infect Dis. 2019;11(2):161\u201376.","journal-title":"Curr Treat Options Infect Dis"},{"key":"1084_CR16","doi-asserted-by":"crossref","unstructured":"Contejean A, Tisseyre M, Canou\u00ef E, Treluyer J-M, Kerneis S, Chouchana L. Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis. J Antimicrob Chemother. 2021.","DOI":"10.1093\/jac\/dkab003"},{"issue":"6","key":"1084_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cmi.2020.03.019","volume":"26","author":"I Bellos","year":"2020","unstructured":"Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN. Acute kidney injury following the concurrent administration of antipseudomonal \u03b2-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect. 2020;26(6):696\u2013705.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1084_CR18","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, D\u00f6bele S, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990\u20131001.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1084_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cmi.2017.11.009","volume":"24","author":"M So","year":"2018","unstructured":"So M, Mamdani MM, Morris AM, Lau TTY, Broady R, Deotare U, et al. Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study. Clin Microbiol Infect. 2018;24(8):882\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"1084_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3324\/haematol.2013.091769","volume":"98","author":"IC Gyssens","year":"2013","unstructured":"Gyssens IC, Kern WV, Livermore DM. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica. 2013;98(12):1821\u20135.","journal-title":"Haematologica"},{"issue":"10","key":"1084_CR21","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.","journal-title":"Clin Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01084-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T19:15:04Z","timestamp":1648494904000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01084-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01084-0","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Committee for publications of the Cochin university Hospital (CLEP) (N\u00b0: AAA-2021-08011). According to French law, this type of observational study does not require any written informed consent from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}